The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis

Annals of Internal Medicine

Volumn 124, Issue 7, 1996, Pages 627-632

  Pedrini, Michael T ^b   Levey, Andrew S ^c   Lau, Joseph ^c   Chalmers, Thomas C ^e   Wang, Ping H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLYCOSYLATED HEMOGLOBIN; PROTEIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DEATH; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MEAN ARTERIAL PRESSURE; META ANALYSIS; PRIORITY JOURNAL; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029917114     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-7-199604010-00002     Document Type: Article

References (26)

1. Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw, M, Zech PY. Controlled low protein diets in chronic renal insufficiency meta-analysis BMJ 1992,304:216-20
2. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease Modification of Diet in Renal Disease Study Group N Engl J Med 1994,330.877-84
3. Striker G. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease J Am Soc Nephrol. 1996;5:1537-40
4. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-54.
5. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes Lancet. 1993;341: 1306-9.
6. Rosman JB, Langer K, Brandi M, Piers-Becht TP, van der Hem GK, ter Wee PM, et al. Protein-restricted diet in chronic renal failure a four year follow-up shows limited indications Kidney Int Suppl. 1989;27:S96-102
7. Ihle BU, Becker GJ, Whitworth JA. Charlwood RA, Kincaid-Smith PS. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med. 1989,321 1773-7
8. Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A. Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency Lancet 1991,337:1299-304.
9. Williams PS, Stevens ME, Fass G, Irons L, Bone JM. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial Q J Med. 1991,81 837-55
10. Jungers P, Chauveau P, Ployard F, Lebkiri B, Ciacioni C, Man NK. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int Suppl. 1987;22:67-71.
11. Ciavarella A, Di Mizio G, Stefoni S, Borgnino LC, Vannini P. Reduced albuminuna after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy Diabetes Care. 1987,10:407-13.
12. Zeller K. Whittaker E. Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1991;324.78-84
13. Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ. Long-term effects of protein-restricted diet on albuminuna and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care. 1993;16:483-92.
14. Barsotti G, Ciardella F, Morelli E, Cupisti A, Mantovanelli A, Giovannetti S. Nutritional treatment of renal failure in type 1 diabetic nephropathy Clin Nephrol 1988;29:280-7.
15. Walker JD, Bending JJ, Dodds RA, Mattock MB, Murrells TJ, Keen H, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy Lancet 1989;2:1411-5
16. DerSimonian R, Laird N. Meta-analysis in clinical trials Controlled Clin Trials. 1986,7 177-88.
17. Robins J, Greenland S, Breslow NE. A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol. 1986,719-23.
18. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38.167-84.
19. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983,23:647-55
20. Donner A. Approaches to sample size estimation in the design of clinical trials - a review Stat Med. 1984;3:199-214.
21. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 1996, [In press].
22. Mitch WE. Dietary protein restriction in patients with chronic renal failure Kidney Int. 1991,40:326-41.
23. Parving HH, Andersen AR, Hommel E, Smidt U. Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension 1985,7(6 Pt 2) 114-7.
24. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med. 1993;329 977-86
25. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group JAMA. 1994,271:275-9
26. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med. 1993;329:1456-62